Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants (Q44606439)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on October 2, 2003

Language	Label	Description	Also known as
English	Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants	scientific article published on October 2, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

5

object named as

Michael Boeckh

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

9

object named as

Lawrence Corey

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Wendy Leisenring

3

object named as

Wendy Leisenring

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

W Garrett Nichols

7

object named as

W Garrett Nichols

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1

object named as

Kieren A Marr

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2

object named as

Fulvio Crippa

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

S. Arunmozhi Balajee

6

object named as

S Arunmozhi Balajee

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Maggie Hoyle

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Benjamin Musher

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

2 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://ashpublications.org/blood/article-pdf/103/4/1527/1695455/zh800404001527.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14525770

17 March 2024

http://ashpublications.org/blood/article-pdf/103/4/1527/1695455/zh800404001527.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1527-1533

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

1

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

2

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

4

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

5

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

6

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

7

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

8

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

9

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

10

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

11

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

12

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

13

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

14

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

16

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

17

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

18

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

22

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Cyclophosphamide metabolism is affected by azole antifungals

23

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

24

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

26

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

27

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.

28

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

29

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

30

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Problems in dealing with missing data and informative censoring in clinical trials

31

1 reference

10.1182/BLOOD-2003-08-2644

https://api.crossref.org/works/10.1182/BLOOD-2003-08-2644

17 March 2024

Identifiers

10.1182/BLOOD-2003-08-2644

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44606439&oldid=2106079270"